Testing an aftercare mobile application for relapse prevention to alcohol and cannabis use among young adults
- Conditions
- Alcohol, cannabis, and other illegal drug substance use disorderMental and Behavioural Disorders
- Registration Number
- ISRCTN74552565
- Lead Sponsor
- Aarhus University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 90
1. Aged 18 – 30 years old
2. Own a mobile with a data plan
3. Enrolling in outpatient treatment for alcohol or cannabis use at one of the participating sites
4. Provision of informed consent to study participation
5. Attends the third treatment session after enrollment in treatment for the provision of the app
1. Severe mental illness (e.g., psychosis) or dangerous behavior (e.g., aggression)
2. Severe neuropsychological disorder or cognitive dysfunction
3. Not willing or able to give informed consent to participate in the study
4. Does not speak or understand Danish in a way that makes it possible to participate in the project
5. Took part in a prior stage of the project that focused on the app development
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> Clinical effect:<br> 1. Seven-day alcohol use measured using the Time Line Follow Back questionnaire (TLFB), at baseline, and 6, and 12-week follow-ups<br> 2. Thirty-day alcohol use measured using a single-item question (How many days have you drank alcohol in the last month?), at baseline, and 6, and 12-week follow-ups<br> 3. Seven-day cannabis use measured using the Time Line Follow Back questionnaire (TLFB), at baseline, and 6, and 12-week follow-ups<br> 4. Thirty-day cannabis use measured using a single-item question (How many days have you used any cannabis products in the last month?), at baseline, and 6, and 12-week follow-ups<br><br> Feasibility and usability:<br> Average use of app measured using the number of clicks on different app functions in the first 6 weeks of use<br>
- Secondary Outcome Measures
Name Time Method <br> 1. Seven-day illicit drug use measured using a single-item question (How many days have you used any illicit drugs, except for cannabis, in the last 7 days?), at baseline, and 6, and 12-week follow-ups<br> 2. Thirty-day illicit drug use measured using a single item question (How many days have you used any illicit drugs, except for cannabis, in the last month), at baseline, and 6, and 12-week follow-ups<br> 3. Depressive symptoms in the last 2 weeks measured using the Patient Health Questionnaire-2 (PHQ-2) and anxiety symptoms in the last 2 weeks measured using the Generalized Anxiety Disorder 2-item (GAD-2), at baseline, and 6, and 12-week follow-ups<br>